Aegis Capital Corp. acted as Sole Bookrunner on a $8.4 Million Follow-On Offering for Medigus (NASDAQ: MDGS)
Aegis Capital Corp. acted as Sole Bookrunner on a $8.4 Million Follow-On Offering for Medigus (NASDAQ: MDGS) About Medigus Medigus and its subsidiaries are focused on medical-related devices and products and on internet and other online-related technologies. Medical related activities include miniaturized imaging equipment through Scoutcam Inc. (formerly known as Intellisense Solutions Inc.), innovative surgical devices with direct visualization capabilities for the treatment of Gastroesophageal Reflux Disease (GERD) using Medigus Ultrasonic Surgical Endostapler, or MUSE, and biological gels ...
Source: finanznachrichten.de